Exercise may improve outcomes for patients with hematologic cancers
the ONA take:
A 12-week exercise rehabilitation program resulted in improvements in cancer-related fatigue and additional outcomes in patients with hematologic cancer following treatment, a new study published online ahead of print in the journal Supportive Care in Cancer has shown.
Because patients with hematologic malignancies exhibit significant physical deconditioning and psychological distress after treatment, researchers sought to evaluate the efficacy of a 12-week exercise rehabilitation on cancer-related fatigue and related outcomes in these patients following treatment.
Researchers enrolled 37 patients and randomly assigned them 1:1 to participate in the 12-week exercise rehabilitation or usual care.
The rehabilitation consisted of tailored exercise programs comprising aerobic and resistance exercises performed three times weekly for 12 weeks in local gyms and clinics. Those in the usual care group were offered a delayed, tailored 12-week exercise program after the initial study period.
The study demonstrated that the 12-week exercise rehabilitation program resulted in significant improvement in cancer-related fatigue, cardiovascular fitness, quality of life, muscle strength, and body composition. The delayed 12-week exercise program also showed similar significant improvements in patient outcomes.
A 12-week exercise rehabilitation program resulted in improvements in cancer-related fatigue.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
- Drug Classification of Trastuzumab
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|